Furthermore, by blocking EMT (a key source of activated fibroblasts) and reducing profibrotic cytokine release (e.g., TGF-β1, IL-6), quercetin indirectly attenuates fibroblast activation and ECM deposition, as evidenced by our BLM model data. The gene discussed is IL6; the disease is Bloom syndrome.